The Nefkens Adrenal Cancer Foundation has been established in September 2024 to support innovative research into adrenocortical cancer (ACC) with clinical impact. On a regular basis funding in the form of grants will be provided. Until February 1th 2025 preproposals can be submitted for obtaining a clinical research grant or a translational research grant. See for more information www.nac.foundation.